Home » Topics » BioWorld Science

BioWorld Science
RSS

FogPharma announces closing of series B financing

May 17, 2018

Hospira obtains FDA approval for epoetin alfa biosimilar Retacrit

May 17, 2018

SNP in ITGA4 gene tied to higher risk of Alzheimer's disease

May 17, 2018

Preliminary results reported from phase Ia/b study of LY-3300054 for solid tumors

May 17, 2018

FDA grants orphan drug designation to Sarconeos for Duchenne muscular dystrophy

May 17, 2018

Phase III study of galcanezumab in episodic cluster headache meets primary endpoint

May 17, 2018

NIAID files IND application for phase IIa study of next-generation pertussis vaccine BPZE-1

May 17, 2018

Sumitomo Dainippon updates pipeline activities of fourth quarter of fiscal 2017

May 17, 2018

Cipher acquires Correvio's Canadian business portfolio

May 17, 2018

Rexahn advances phase IIa study of RX-3117 and Abraxane in metastatic pancreatic cancer

May 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...